KR20100028150A - Lipolysis equipment with broadband ultrasound and broadband laser radiation - Google Patents

Abstract

PURPOSE: An obesity treating device is provided, which makes biochemical effect by the ultrasonic wave amplified by irradiating laser light. CONSTITUTION: An obesity treating device is constituted as follows. The broadband ultrasonic wave and broadband laser light are radiated to the obesity portion. The broadband ultrasonic energy and broadband optical energy are irradiated to the fat part at the same time. The decomposition of the lipid accumulated at fat tissue is promoted.

Description

 Obesity treatment device using broadband ultrasound and broadband laser light {Lipolysis equipment with broadband ultrasound and broadband laser radiation}

Irradiation of broadband ultrasound energy and broadband light energy at the same time, as synergistic stimulation, to promote the decomposition of lipids accumulated in adipose tissue, and to effectively develop the obesity treatment device having the function of effectively promoting the metabolism of FFA released into the bloodstream Related field

    In the recent well-being era, health and body care have become one of the major concerns for many people. It is well known that excessive body fat accumulated in various parts of the body not only causes various diseases, but also directly causes the body's proportionation. Therefore, in recent years, efforts have been reported to effectively remove such local excess fat layer by painless and non-invasive means.

 The body fat accumulated in the living body is basically caused by the amount of calories ingested as food more than the calories consumed by the body's basic metabolism and exercise. Therefore, the basic method for removing body fat can be said to promote fat metabolism with sufficient aerobic exercise with control of calorie intake through fasting. However, this method involves not only a few physical and mental pains, but also many people give up due to their own environmental factors.

 In recent years, lipo-suction has been introduced as a direct method for fat removal, so that body fat in a desired area can be physically removed. However, the surgical method includes not only fat cells but also peripheral nervous system, blood vessels and muscle tissue. In some cases, the back may be damaged, causing the operator to feel a lot of pain, and in some cases, may have a sequelae and side effects. Therefore, non-invasive and non-surgical therapies have been proposed that can remove excess body fat in desired areas in a more comfortable and safe way without performing such surgical procedures.

  Representative examples thereof include a method of irradiating ultrasound to a site where body fat is excessively accumulated (hereinafter abbreviated as a target site) such as Korean Patent 2001-0040668, 2001-170128, and US Patent 20070055154, 6,645,162, 20060094988, and US Patent 20060265032. There is a method of irradiating infrared rays, and a method of irradiating high frequency electromagnetic fields such as U.S. Patent No. 5143063, 5507790, all of which irradiate an ultrasonic, infrared, or high frequency electromagnetic field to a target site, and the fat in adipocytes as a pyrogenic effect. Melt and release to intercellular space, or by using the ultrasonic cavitation (cavitation) effect, physically destroy the cell membrane of fat cells to release fat.

Since this method requires the application of energy close to the limit of the safety standard to the living tissue, it requires real-time observation of the target site and its surrounding tissue and precise control of the output. In particular, the method of irradiating ultrasonic waves of several W / cm ² level in the range of 1-4 MHz adopted by the above patent is very close to the MI (mechanical index) or TI (Temperature Index) limit for the human body. .

 In addition, it aims to promote lipolysis and fat metabolism by applying a low frequency current to muscle tissue as in Korean Patent 10-0502462 to apply electrical stimulation. However, there is a significant risk in terms of safety of electrical energy without accurate measurement and understanding of the electrical properties of these tissues, such as the injection of appropriately sized electrical energy into the muscle layer via the epidermis, dermis and subcutaneous fat layer from the electrode in contact with the skin surface. This is accompanied by. Moreover, the electrical properties of these tissues vary greatly depending on the individual or the treatment environment, requiring a precise control system. In the absence of such considerations, electric shocks due to overvoltage, burns on electrode contact surfaces due to overcurrent, or damage to nearby tissues have been reported.

Recently, a method of releasing fatty acids from adipocytes by inducing a biochemical response of cellular tissues by applying a weak ultrasonic wave of several 10 mW / cm ² to a living body has been proposed. This phenomenon is largely due to the fact that in the tissues with weak ultrasonic waves in the range of several 10KHz to several MHz, there is a significant increase in blood noradrenalin (NA) and free fatty acid (FFA). Known in This phenomenon is caused by the use of ultrasound energy to stimulate the sympathetic nervous system of the irradiated site, even without the command of the brain, neurotransmitters such as nore adrenaline, adrenaline, or sympathetic nerve terminals (Adrenal medula). It is known that these hormones are released in large quantities, and these hormones are known to activate the lipase in the vesicles of adipocytes, thereby decomposing fat cells of the adipocytes into FFA and releasing them into the intercellular space. This phenomenon can be seen as a biochemical effect on the living body by relatively weak ultrasonic waves of several tens of mW, and the prior patents, such as a powerful energy of several W / cm ² level to the physical effect such as heat generation or cavitation on the living tissue It is different from what is caused.

The method to be adopted there is the Republic of Korea Patent 2001-0040668, in which 15KHz - is by examining the target site with the output of 800mW / cm ² range of 1.3MHz ultrasonic range 4mW / cm ^2. However, this patent does not specify the ultrasonic frequency to be applied, but only theoretically derives and collectively designates the frequency range under which the ultrasonic irradiation output falls below the MI safety standard value. Methods, means, etc. are not specified. Therefore, the therapeutic effect and reproducibility in clinical practice cannot be predicted.

  Japanese Patent Application Laid-Open No. 2004-089261 uses the same principle as this. In this case, 500kHz-530kHz is specified as a specific frequency, and when the human body is irradiated with ultrasonic waves in this frequency band, the sympathetic nerve is stimulated in the region, which stimulates the secretion of NA, and the action of this hormone releases a large amount of FFA from fat cells. have.

  In addition, Japanese Patent Application Laid-Open No. 2001-170128 also describes a method using this principle, in which all stimuli capable of stimulating the sympathetic nervous system, such as low and medium frequency electrical stimulation, ultrasonic stimulation, heat and cold stimulation, and laser light, All physical stimuli, such as stimuli, even beating, stroking, kneading, etc. can be used for this purpose, and these are comprehensively incorporated in the claims. It is common sense that these physical stimuli stimulate the sympathetic nervous system, and the problem is that specific forms of how these stimuli contribute to the secretion of NA, such as the frequency according to the type of stimulus, the means and methods of application, etc. As it is not defined, it can be considered meaningless for clinical application. The reason is that these physical stimuli not only act on the sympathetic nervous system but also affect nearby tissues. Depending on the intensity, frequency, and method of stimulation, fat removal may not be effective. This may result in a risk and may also cause a variety of side effects.

In summary, the physicochemical effects of these ultrasonic waves on living bodies are reported to occur in a wide range of frequencies of 20 kHz to 1,500 kHz and energy intensities of 5 mW to 1,000 mW / cm ² . However, the characteristic of this effect is that there is no clear correlation between applied frequency and applied energy intensity.

  For example, when applying the ultrasonic energy of various frequencies to the target site, the point where the NA secretion effect is above a certain level is indicated on the fp plane (frequency (Hz)-energy intensity (W) plane), It is known to show an extremely random distribution such as 1. This is because the channel opening and closing characteristics of the NA storing vesicle of the sympathetic nerve endings of the human body may be caused by extremely discrete response to external stimuli such as ultrasound. Therefore, it is almost impossible to predict the optimum frequency and optimal power for this effect. As a result, as has been attempted by several prior patents, it can be seen that recommendation of the optimal value to the clinical by setting a specific frequency and energy value has little reproducibility and does not mean much.

Meanwhile, a method of using laser light for lipolysis has also been reported. In US Patent 20050203594, when a low power laser light of 635 nm and 10-20 mW is irradiated around 1.2-3.6 J / cm ² around the waist, adipocytes It is said that a significant amount of lipids in the body can be released into the interstitial space. In addition, the published experimental results show that, when irradiated with a weak laser light of 635 nm for 4-6 minutes, a transient space is formed in the cell membrane of adipocytes, resulting in up to 99% of lipids in the cells. It has been reported to have been released out of the cell.

  However, this experiment is a case where the laser light is directly irradiated on the surface of the fat cells, and if the fat cells are irradiated outside the epidermis as in the non-invasive procedure, the light energy is attenuated considerably in the epidermal layer, so the lipolysis effect will be greatly reduced. Experiments show that light in the 600 nm band is already attenuated by 80% in the epidermis and the rest reaches the subcutis. Therefore, the output of the irradiation light source should be increased or the irradiation time should be increased. If the former is used, the epidermal layer may be damaged by the heat generation effect of the light energy. If the latter is selected, the irradiation time is lengthened, which is impractical. The FFA released in the tissue attack cannot be expected to be totally reduced because most of the FFA is absorbed into the original fat cells or the fat cells of other parts unless it is burned, decomposed and released in vitro. FFA present in the human body tissue attack or blood flow is basically decomposed into carbon dioxide and water by the body's thermoogenesis, basic metabolism and exercise metabolism, and released into the body. Basic metabolism is generally constant according to the individual's constitution and age, so the rest of the FFA should be consumed through an appropriate amount of aerobic exercise.

   Recently, the metabolic rate of the human body has been found to be different in the activity of the uncoupling protein family (UCP), and if activated efficiently by physical stimulation, this protein family consumes FFA without aerobic exercise. It turns out that you can. UCP is present in brown adipocytes, skeletal muscle, myocardium and white adipocytes and is known to be activated by stimulating the sympathetic nervous system.

According to the experiments, when the ultrasonic wave in the range of 20kHz-1500kHz is 5mW-1000mW / cm ² and irradiates the target area where fat is accumulated, NA and FFA are remarkably increased in the tissue space and blood vessel of the irradiated area. It has been reported that lipolysis occurs even in the absence of instructions from the brain. Therefore, if this method is actively used for lipolysis, it is possible to implement a safe and efficient obesity treatment device as a relatively simpler system than other methods. However, this effect does not correlate well with the frequency and power of the irradiation wave, resulting in an extremely random distribution, making it very difficult to predict the frequency and intensity most effective for lipolysis of a given site. Difficult and therefore less reproducible.

  Now, if the frequency (kHz) and the intensity (mW) of the irradiation wave in which the secretion of NA and FFA are increased by a certain amount by irradiating ultrasonic tissues on the fp plane as shown in Fig. 1 are a1, a2, .. ., the same point as an (hereinafter referred to as stimulus point). However, because the distribution varies from individual to individual, from site to site, and from environmental conditions, it is almost impossible to predict this and there is no reproducibility. Therefore, one of the main subjects of the present invention is to easily find countless stimulus points scattered in this way, and to find a method for clinical application by investigating frequencies and power values corresponding thereto.

 Despite these efforts, there may be cases in which such ultrasonic stimulation alone does not provide sufficient lipolytic effects. The reason for this is that there is a difference in the response characteristics of lipolysis-related tissues including the sympathetic nervous system to the ultrasound. The present invention is characterized by amplifying a biochemical effect by ultrasonic waves by overlapping and irradiating laser light, which is another energy source, to the same target site. That is, when the stimulation intensity of the ultrasonic energy does not exceed the threshold level due to any cause and the emission of FFA is extremely weak, when the energy of the laser light is superimposed thereon, the stimulation intensity exceeds the threshold and the lipolysis action occurs. It can be promoted more reliably.

 The main task when using laser light for lipolysis is to derive the optimum value of the wavelength and irradiation intensity of the laser light to be irradiated and to develop the irradiation means. According to the published results, up to 99% of the fat in the adipocytes can be freely released into the FFA by using a laser beam of 635 nm wavelength. However, this is the case where the laser light is directly irradiated on the surface of the sampled fat cells, and in fact, because the laser light is irradiated to the epidermis, there is a considerable amount of attenuation until the energy penetrates inside and reaches the fat cells. These results cannot be applied to the clinic as it is. In general, although the attenuation rate of light in the epidermal layer depends greatly on the state of the epidermis, it is known that at least 80% of incident light attenuates. Therefore, depending on the location of the fat layer, it may be considered that there is a lack of light energy and a sufficient fat decomposition effect is not expected. In this case, it is necessary to greatly increase the laser power of 635 nm to compensate for the amount of attenuation in the epidermis. This method increases the amount of heat generated in the epidermis and burns the skin, and the fat cells present in the light propagation path. Since other cells may be unnecessarily damaged, countermeasures against it are necessary.

  Another major issue is the issue of local metabolism. FFA, which is decomposed into fat and absorbed in the middle attack or bloodstream, is decomposed into water and carbon dioxide by the body's natural metabolism, but excreted in vitro, but it is necessary to impose a considerable amount of aerobic exercise in the constitution lacking basic metabolism. Recently, a method for increasing fat metabolism by stimulating UCP or BAT and promoting thermal production has been developed. Applying this method, since a sufficient amount of fat metabolism can be obtained with a relatively small amount of aerobic exercise, the present invention also needs to develop an effective stimulation method of UCP and BAT.

  The present invention, as defined in claim 1 as a means for solving the above problems by simultaneously irradiating broadband ultrasonic energy and broadband optical energy to the target site, and promotes the decomposition of lipids accumulated in adipose tissue as synergistic stimulation In addition, it is characterized in that the obesity treatment device having a function of effectively promoting the metabolism of FFA released into the bloodstream.

   The obesity treatment device includes ultrasound irradiation means including at least one broadband ultrasonic transducer, light irradiation means including at least two LDs or LEDs, and a combination of these, ultrasound and light energy at a target site. It is characterized in that it is composed of a control unit (Applicator Unit) made so that it can be applied (apply), and a control / power unit having a power supply and optimum control function for them.

  The most important thing in lipolysis using ultrasound is to derive the optimal condition of ultrasound to be investigated. Now, when an ultrasonic wave of frequency f1 is irradiated to a specific power switch by a specific power p1, if the blood FFA increases by a certain value, the waves defined by f1 and p1 can be regarded as one of the optimum stimulus waves for this target site. According to the measurement results, there are a large number of such optimum stimulus waves in a general target region, and when they are displayed on the f-p plane, they appear as extremely random distributions in the shape of points a1, a2, ..., an in FIG. In clinical practice, it is ideal to accurately select the frequency f (kHz) corresponding to this point (hereinafter referred to as the stimulus point) and to irradiate the site accurately as the output p (mW). Or because it depends on the research environment, it is almost impossible to predict in advance. Therefore, in the present invention, as shown in Fig. 1, the frequency of the irradiated ultrasonic waves can be diffused in a range, and the power can be sweeped in a range, thereby facilitating the capture of a desired magnetic pole point. For example, in order to stimulate the magnetic pole point a1, if the power is varied in the range of the wave spreading in the frequency range, the optimum magnetic pole point can be stimulated very easily. In addition, since the diffusion range can be expanded to include six stimulus points a1, ..., and a6 simultaneously, there is no need to search for a specific stimulus point, and the power reduction caused by diffusion can be compensated for. Overall power efficiency is greatly improved and the therapeutic effect is increased.

  The invention of claim 2 is a method of diffusing ultrasonic energy for this purpose, characterized in that a frequency sweep signal having the characteristics as shown in FIG. 2 (a) is applied to at least one broadband ultrasonic transducer. . At this time, the sweeping frequency range is determined by experiment within the range of 20kHz to 1200kHz according to the characteristics of the target site. In general, the ultrasonic transducer has an upper limit frequency, so in order to obtain a sufficient sweep range, it is preferable to divide the beam into several small bandwidths and irradiate them as independent transducers. 2 (b) is a case of using three sweep converters to sweep as three small bandwidth transducers each having a sweep width of.

  The invention of claim 3 is another method of diffusing ultrasonic energy, which uses at least one ultrasonic transducer and phase modulates its output as a sinusoidal wave of a certain period, thereby generating a plurality of sideband waves. It is characterized in that to form a predetermined bandwidth as. This increases the probability that one of the countless sidebands contained within stimulates the stimulus point, so that the same effect as the above described claim 3 can be obtained. At this time, the sideband bandwidth is determined by experiment within the range of 20kHz to 1500kHz according to the characteristics of the target site. The set size of can be implemented by calculating the size of the modulation index and the frequency of the modulation signal by applying the following equation.

 If we consider the case where the transducer's output frequency is CW (Continuous Wave) and we phase-modulate it with the sinusoidal wave, it can be expressed as Where is the amplitude of the wave, is the modulation index, and is the Bessel function of the first kind. When this equation is shown, 2 (c) and a split spectrum are shown, and it can be seen that countless sidebands are generated at intervals of frequencies above and below the CW position. 2 (c) shows the case where. The magnitude of the sidebands decreases with higher orders, but the energy is in the range of 95% of the total energy. Therefore, we designate small square width and design all the desired magnetic pole points within this range. For example, if we want to have the sweep bandwidth, we can design the modulation circuit to be.

 Another means to promote lipolysis is to irradiate the subcutaneous fat layer with light energy of a specific wavelength to change the cell membrane of white fat cells to permeability to release the lipid inside directly into tissue attack. For this method, the use of 625 nm laser light has been widely reported. However, in this wavelength band, the attenuation rate in the epidermal layer is high, so most of the light irradiated on the epidermal surface is absorbed in the epidermal layer, so the transmission depth is less than 1-2 mm. . Therefore, it is difficult to expect a sufficient lipolysis effect because the light energy reaching the fat layer is small depending on the irradiation part.

  The light transmittance of the human tissue is affected by the melanin pigment in the epidermal layer and the moisture and hemoglobin components in the dermis and subcutaneous tissue. In general, the absorption rate is relatively low in the range of 650 nm to 950 nm to show window characteristics. Experiments have shown that in this window region, light generally transmits to depths of 2-5 mm. The relationship between the wavelength of the laser light and the emission amount of the FFA is also less correlated with each other, and there is a large difference depending on variables such as the irradiation site, irradiation power, and patient constitution. Therefore, the light source of a single wavelength cannot guarantee the optimum irradiation wavelength.

The invention of claim 1 and claim 5, in view of this point, in order to cover the 650nm-950nm range corresponding to the window as much as possible in the light transmission characteristics of the human tissue, a plurality of LDs having different wavelengths The method of irradiating broadband light is used in combination. In this case, select LD with at least two different wavelengths in the 650-950nm band, and the applied power is within the range of 10mW / cm ² ~ 500mW / cm ² of irradiation energy per unit viewing area. Be sure to Moreover, it is preferable to attach a diverging lens to all LDs, and to use it, spreading an irradiation area suitably.

 In claim 5 of the present invention, the LED is also used as a light emitting device. The output light of the LED is not a coherent light, so that the fat emission effect may be somewhat reduced, but the wavelength spectra is laser semiconductor. It can be replenished by extending the irradiation time by showing wider distribution.

 In general, when irradiated with low-power laser light, the photo-chemical effect has been found to be effective in activating the cellular function of the irradiated site, increasing blood flow, capillary growth, and promoting APT production. Low Level Laser Therapy) has already been applied in clinical practice. The FFA released to the tissue attack is mainly burned through the body's basic metabolism or exercise metabolism, etc., and is discharged to the outside of the body. In other words, it is used to promote fat metabolism through the increase of blood flow in the irradiated site, increase of lymph flow and activation of cellular tissues.

 Therefore, the irradiation unit of the present invention 1 may be used for the purpose of lipolysis or fat metabolism depending on the irradiation site, and in some cases may achieve the same two purposes.

 It has been reported that the laser light for LLLT is more effective for pulse modulated waves that are on-off with a constant period than for continuous waves. Therefore, in claim 7 of the present invention, the output light of the LD is interrupted at a period of 3-10 uS.

  When irradiating a living tissue by modulating the laser light into a pulse wave, it is known to generate a small photo-acoustic effect on the irradiation site. Therefore, if the laser light is on-off modulated by pulse wave in the range of 20kHz-1200kHz, ultrasonic vibration of this frequency range is generated at the irradiation site, and it stimulates the sympathetic nervous system in the vicinity to increase the secretion of NA. It further promotes lipolysis. In particular, if the pulsed laser light is selectively irradiated to stimulate uncoupling protein (UCP) and brown fat in each part of the body, it promotes thermal production and metabolism, thereby enabling more effective fat removal.

   The invention of claims 2, 3, and 4 is to diffuse the ultrasonic energy widely on the f-p plane to evenly include more lipolysis stimulation point, the efficiency of lipolysis is higher than the conventional method.

  In addition, the invention of claim 5,6,7 maximizes the photo-chemical effect by widening the total synthetic spectra width of the irradiation light to cover the entire light transmission window range of the human tissue, thereby improving the lipolysis efficiency by the light energy At the same time, it is possible to achieve metabolic promotion by the LLLT effect. In particular, by modulating the light output into pulses of several 100 KHz, lipolysis and metabolism promotion using photo-acoustic effects can be expected.

  In addition, the invention of claim 9 makes it possible to easily implement an irradiator of any size by appropriately combining a small irradiating module according to the area of the irradiated portion, thereby greatly expanding the application range of the present treatment device.

  In conclusion, the obesity treatment device defined in claim 1 is irradiated with the ultrasonic energy of the broadband formed by the interference wave of the plurality of transducers and the optical energy formed by the plurality of pulse-modulated light emitting devices at the same time. Lipolysis and fat metabolism can be more effectively achieved.

(Example 1)

   The present invention will be explained by taking Example 1 as an example.

   The system consists of an irradiation unit 100 attached to the body to irradiate ultrasonic and light energy and a power supply / control unit 500 for supplying power to and controlling the irradiation unit.

   The irradiation unit in the first embodiment has a form in which four irradiation modules 10 as shown in FIG. 3 are attached to the fixing band 20 in one pair. When it is necessary to examine a wider area, six or more irradiation modules can be combined and used in a wide bag.

   The irradiation module 10 serving as the basic unit of the irradiation unit 100 has a structure as shown in FIG. 3 in which one ultrasonic transducer 11 and four light emitting elements 12 are mounted. The ultrasonic transducer and the light emitting element are assembled on the flexible PCB 14 and the PCB is bonded to the flexible plastic substrate 15. The ultrasonic element 11 has a spring 112 attached to the front thereof, and when in use, pressure is applied to be in close contact with the skin surface. The carriage 111 accommodates the spring and at the same time prevents the displacement of the ultrasonic transducer in the horizontal direction. At the periphery of the module, pads 13 are placed on the skin surface to serve to support the module. Pad 13 is made of a sponge material, the height of the light emitting device and the surface of the skin is maintained at a constant interval, the transducer is determined to be pressed to the skin surface at a suitable pressure by spooling. In addition, a temperature sensor 16 is embedded in the pad 13 so that the temperature of the contacted skin surface can be measured in real time.

 In Example 1, each module is equipped with an ultrasonic transducer of a different frequency, the module 10a is equipped with a transducer 11a, the module 10b is equipped with a transducer 11b. Transducer 11a sweeps the 50 kHz-200 kHz range by sweep signal generator 511a, and 11b sweeps the 200-800 kHz range by sweep signal generator 511b.

 The light emitting diodes 12 of each module use four LDs or LEDs having different light emission wavelengths. These light emitting devices use output wavelengths in the range of 650nm to 950nm, but they are selected so that the overall synthetic spectra are evenly distributed over the entire wavelength range. All the light emitting elements are attached with diverging lenses to diverge the light into a larger area. The light output of all light emitting devices is modulated with a square wave pulse of 500-1000 KHz.

 The power supply / control unit 500 is configured as shown in FIG. 6 to drive the ultrasonic elements and the light emitting elements as separate drivers. The ultrasonic driver 511 controls the on-off of oscillation and its output with respect to each ultrasonic transducer 11n according to the instruction | command of CPU. The light emitting device driver 512 turns on and off a total of eight light emitting devices 12n according to a command from the CPU, and also controls the pulse frequency during the pulse operation. The sensor signal processor 513 receives the signal from the sensor, processes it, and transmits the signal to the CPU. The CPU receives the output of the sensor signal processing unit, makes a necessary judgment according to the built-in program, and sends a command to each driver again.

(Example 2)

 The present invention will be described taking the second embodiment as an example.

 In the second embodiment, the treatment apparatus includes an irradiator 100 having two irradiation modules 10 as shown in FIG. 7, and a power supply / control unit 500 for supplying power and controlling the same in the hard plastic case 30. Built together. When it is necessary to examine a wider area, a large irradiator may be assembled by arranging four or more irradiation modules.

 The treatment device is waterproof so that it can be used in the bathroom.

1: A model diagram illustrating the distribution of magnetic pole points and the scanning range of f and p

Figure 2a: sweep pattern with time of ultrasonic frequency

Figure 2a: f-p plane divided into a plurality of sweep regions

Fig. 2a: A model of sideband band generated by phase / frequency modulation of CW

3 is a plan view and a cross-sectional view of an applicator module serving as a structural unit of the light irradiation unit.

4 is a front view and a sectional view of the irradiation unit of Embodiment 1 configured as four irradiation modules;

5: Example of use of Example 1

Fig. 6: Block diagram of the power supply / control unit

7: Model diagram of Example 2

<Description of main drawing code>

 10n Applicator Module (n = a, b)

    Module with 10a ultrasonic transducer 11a

    Module with 10b ultrasonic transducer 11b

 11n ultrasonic transducer (n = a, b)

    Ultrasonic Transducer with 11a Frequency Fa

    Ultrasonic Transducer Generates 11b Frequency fb

    111 transducer carriage (accommodates transducers and springs, enabling shandong)

    112 Transducer Crimp Springs (springs for compressing ultrasonic transducers to the skin surface)

 12n light emitting device LD / LED device (n = a, b, c, d)

    LD or LED generating 12a wavelength a

    LD or LED generating 12b wavelength b

    LD or LED generating 12c wavelength c

    LD or LED generating 12d wavelength d

 13 Skin Contact Pad

 14 Flexible PCB (Flexible PCB))

 15 Flexible Base Plate

 16 temperature sensor

 20 Mounting band (mounting fixture for fixing the irradiation unit to the treatment area)

 30 cases

100 Applicator Unit

500 Power / Control Unit

521 power line

Claims (11)

  By irradiating broadband ultrasound energy and broadband light energy at the same time, the synergistic stimulus promotes the decomposition of lipids accumulated in adipose tissue and promotes the metabolism of free fatty acids released into the tissue gap and blood stream. Obesity treatment device, characterized in that provided   The ultrasonic energy irradiation means according to claim 1 is characterized in that it is configured as a sweep signal generator including at least one or more broadband transducers. At this time, the sweep range can be arbitrarily set within the range of 20kHz to 1500kHz according to the characteristics of the target site. However, if the sweep range is wide and it is difficult to sweep the entire band as one transducer, it can be divided into a plurality of subbands. It is characterized by individually sweeping as a producer.   In another energy irradiation means of claim 1, the output of at least one or more ultrasonic transducers is phase- or frequency-modulated as a sine wave of a predetermined period, so that a band of a plurality of sideband waves generated at that time is predetermined. It characterized in that the bandwidth of. In this case, the bandwidth of the sideband is set by experimenting the appropriate bandwidth within the range of 20kHz to 1500kHz according to the characteristics of the target area, but if the bandwidth required is wide to cover as a single transducer, it is divided into a plurality of small bandwidths Each of them is characterized in that to generate sidebands individually as independent transducers. Ultrasonic sound field to be formed in the claim 2 and claim 3 is the power of the irradiation on the skin surface 10mW / cm ² - it is characterized in that it is to be variable within the scope of 1000mW / cm ^2.   The light energy irradiation means according to claim 1 is characterized in that it is an obesity treatment device characterized in that it is configured as LD or LED of at least four or more different wavelengths.   LD or LED according to claim 5 is characterized in that the output wavelength is selected within the range of 650nm-950nm.   LD or LED according to claim 6 is characterized in that the output light is on-off modulated as a pulse signal in the range of 20 kHz to 1200 kHz.   Obesity treatment device according to claim 1, characterized in that it uses the LLLT (Low Level Laser Theory) effect of LD and LED as one of means for promoting metabolism.   The ultrasonic transducer and the LD / LED according to claim 2, 3, and 5 are assembled on the same flexible substrate to form a small irradiation module, and a fixed type or a movable type by combining an appropriate number according to the irradiation site. Obesity treatment device, characterized in that the configuration of the applicator unit (Applicator Unit)   The irradiation module of claim 9 is characterized by controlling the optimum irradiation time irradiation intensity by a program that is built separately to the temperature sensor, and safety management.   The treatment device of claim 1 may be implemented as a portable, manual treatment device of a power supply type in which an irradiation unit and a power / control unit are integrally assembled.

Images